Otto Bock Healthcare Products GmbH — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
EXOPULSE Mollii Suit and EXOPULSE SuitThe objective is to explore the potential short and long-term impact of the EXOPULSE Mollii Suit and EXOPULSE Suit on subjects with CP, MS, stroke, fibromyalgia or other neurologic disorders which may cause such types of symptoms, and to identify high responders among the sub-categories of the diagnoses. The primary endpoint will be improvements in the Berg/Pediatric Balance Scale (BBS/PBS) as a measurement of balance and risk of falls.	Myopathies, SEP	À vérifier	Traitement symptomatique	Sweden	À vérifier
EXOPULSE Mollii Suit and EXOPULSE SuitThe objective is to explore the potential short and long-term impact of the EXOPULSE Mollii Suit and EXOPULSE Suit on subjects with CP, MS, stroke, fibromyalgia or other neurologic disorders which may cause such types of symptoms, and to identify high responders among the sub-categories of the diagnoses. The primary endpoint will be improvements in the Berg/Pediatric Balance Scale (BBS/PBS) as a measurement of balance and risk of falls.	Myopathies	À vérifier	Traitement symptomatique	Sweden	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
EXOPULSE Mollii Suit and EXOPULSE Suit	Myopathies	À vérifier	NCT05901259	EXOREG — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.